HK1213812A1 - M10c1 compound and active ingredient-containing composition and preparation method thereof m10c1 - Google Patents

M10c1 compound and active ingredient-containing composition and preparation method thereof m10c1

Info

Publication number
HK1213812A1
HK1213812A1 HK16101910.7A HK16101910A HK1213812A1 HK 1213812 A1 HK1213812 A1 HK 1213812A1 HK 16101910 A HK16101910 A HK 16101910A HK 1213812 A1 HK1213812 A1 HK 1213812A1
Authority
HK
Hong Kong
Prior art keywords
compound
preparation
active ingredient
containing composition
composition
Prior art date
Application number
HK16101910.7A
Other languages
Chinese (zh)
Inventor
崔坤元
梁東
陳波
Original Assignee
Xiamen Chengkun Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xiamen Chengkun Biotech Co Ltd filed Critical Xiamen Chengkun Biotech Co Ltd
Publication of HK1213812A1 publication Critical patent/HK1213812A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK16101910.7A 2015-08-03 2016-02-19 M10c1 compound and active ingredient-containing composition and preparation method thereof m10c1 HK1213812A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510466904.8A CN105079021A (en) 2015-08-03 2015-08-03 Combination containing M10C1 compound and active ingredient and preparation method of combination

Publications (1)

Publication Number Publication Date
HK1213812A1 true HK1213812A1 (en) 2016-07-15

Family

ID=54560952

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16101910.7A HK1213812A1 (en) 2015-08-03 2016-02-19 M10c1 compound and active ingredient-containing composition and preparation method thereof m10c1

Country Status (3)

Country Link
CN (1) CN105079021A (en)
HK (1) HK1213812A1 (en)
WO (1) WO2017020826A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105079021A (en) * 2015-08-03 2015-11-25 厦门成坤生物技术有限公司 Combination containing M10C1 compound and active ingredient and preparation method of combination

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2762095A1 (en) * 2009-05-16 2010-11-25 Kunyuan Cui Compositions comprising cationic amphiphiles and colipids for delivering therapeutic molecules
CN103189057B (en) * 2010-08-26 2015-02-18 崔坤元 Lipomacrocycles and uses thereof
CN103333890B (en) * 2012-12-21 2015-04-15 厦门成坤生物技术有限公司 RNA interference preparation used for treating viral hepatitis B
CN104107437B (en) * 2013-06-09 2015-08-26 厦门成坤生物技术有限公司 A kind of RNA being used for the treatment of hepatitis B disturbs composition and method of making the same
CN105079021A (en) * 2015-08-03 2015-11-25 厦门成坤生物技术有限公司 Combination containing M10C1 compound and active ingredient and preparation method of combination

Also Published As

Publication number Publication date
WO2017020826A1 (en) 2017-02-09
CN105079021A (en) 2015-11-25

Similar Documents

Publication Publication Date Title
EP3299369A4 (en) Pyrido-azaheterecydic compound and preparation method and use thereof
EP3130354A4 (en) Posaconazole pharmaceutical composition and preparation method, application and pharmaceutical preparation thereof
IL253538B (en) Heterocyclic compound and pharmaceutical composition comprising same
SG11201605868XA (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
PT3202759T (en) Alpha-aminoamide derivative compound and pharmaceutical composition comprising same
HK1243927A1 (en) Composition containing theasapogenol derivative as active ingredient
SG11201610636VA (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
IL251456A0 (en) Compound having gpr119 agonistic activity, method for preparing the same, and pharmaceutical composition including the same as effective component
EP3391884C0 (en) Transdermally absorbable preparation
EP3323825A4 (en) Polypeptide compound and preparation method and use thereof
HK1214767A1 (en) Tablet-formed pharmaceutical composition and preparation method thereof
EP3315508A4 (en) Polypeptide compound and preparation method and use thereof
EP3284743A4 (en) Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof
SI3250188T1 (en) Pharmaceutical composition comprising aprepitant and method for the preparation thereof
IL262929A (en) Composition, and application and pharmaceutical preparation thereof
IL258675A (en) Mosquito activating formulations
IL254597A0 (en) Crystalline form of ahu377, preparation method and use thereof
EP3305283A4 (en) Stabilized pharmaceutical composition and method for preparing same
EP3135299A4 (en) Active ingredient (i) containing composition and method for preparing same
HK1213812A1 (en) M10c1 compound and active ingredient-containing composition and preparation method thereof m10c1
EP3251672A4 (en) Pharmaceutical composition and preparation method therefor
AP2017009706A0 (en) Pharmaceutical compound comprising 13 glycerides, formulation and application thereof
PL3072529T3 (en) Composition comprising vemurafenib and hpmc-as
PT3383402T (en) Pharmaceutical composition comprising darunavir and method for the preparation thereof
ZA201404522B (en) Pharmaceutical composition comprising an anticonvulsant active agent and method for the preparation thereof